Deans' stroke musings

Changing stroke rehab and research worldwide now.Time is Brain!Just think of all the trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 493 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It's quite disgusting that this information is not available from every stroke association and doctors group.
My back ground story is here:http://oc1dean.blogspot.com/2010/11/my-background-story_8.html

Tuesday, October 4, 2016

Marijuana Company of America Announces PreLaunch of HempSMART Brain: a Hemp Derived CBD Product to Support Brain Function

I see no research supporting anything here.
http://www.bloomberg.com/press-releases/2016-10-04/marijuana-company-of-america-announces-prelaunch-of-hempsmart-brain-a-hemp-derived-cbd-product-to-support-brain-function
Marijuana Company of America Announces PreLaunch of HempSMART Brain:
a Hemp Derived CBD Product to Support Brain Function

BONSALL, CA -- (Marketwired) -- 10/04/16 --  MARIJUANA COMPANY OF
AMERICA (OTC PINK: MCOA) -
--  Cutting Edge Research and Premium Botanical Ingredients
--  Company Expects To Ship Orders in October
MARIJUANA COMPANY OF AMERICA ("MCOA" or the "Company") (OTC PINK:
MCOA), an innovative cannabis and hemp marketing and distribution
company, is pleased to announce the prelaunch of the hempSMART Brain
product has commenced.

"We are very excited to announce the hempSMART Brain prelaunch as we
prepare to begin shipping orders in the coming weeks. A lot of time
and energy went into developing this product and we are looking
forward to getting it into the hands of our customers," said CEO,
Donald Steinberg.

hempSMART Brain was developed to address the increase in neurologic
and neurodegenerative challenges that have prompted a surge in
scientific research on prevention and/or reversal of brain and
nervous system pathology. A variety of natural products have been
shown, in clinical trials, to improve neurological and cognitive
function and there has been a surge of products being marketed to
improve brain function. While the efficacy of some of these blends
has been impressive, many utilize trace amounts of therapeutic
ingredients, inadequate for any clinical effect.

Advantages Of HempSMART Brain Over Competing Brain Function Products

HempSMART Brain is unique in that it utilizes a synergistic blend of
natural neuroprotective and neuroregenerative compounds, all in
clinically researched and verified therapeutic amounts. The Core
Ingredients for this product are CBD, Astaxanthin, Phosphoryl Choline
and Phosphatidyl Serine. Together, these ingredients promote and
support brain function and neurogenesis. Additional natural compounds
compliment the synergistic effects of the core ingredients.

HempSMART exemplifies the practical application of cutting edge
research and premium botanical ingredients, in therapeutic amounts.
HempSMART Brain is the first of its kind. The synergistic blend of
clinically verified natural brain support, with water soluble CBD,
crosses the blood-brain barrier and offers brain support and
protection not previously available in the marketplace.

Sales and Marketing Efforts Anticipate Pre-Orders Within Weeks

The hempSMART prelaunch website: www.hempSMART.com is now active and
accessible by the Company's members. Direct Sales leaders have been
invited to join our prelaunch and begin referring others. This
prelaunch will provide an indication of initial demand as orders are
booked in the coming weeks, enabling management to adjust the
manufacturing pipeline accordingly. The hempSMART Brain product is
currently in production and is expected to ship in October 2016.

Investors are invited to visit the MCOA IR Hub on Agoracom to post
questions and receive answers, or review questions and answers
already posted by fellow investors. In addition, the MCOA IR HUB
provides a monitored forum for investors and prospective shareholders
to communicate within a clean, professional environment.

No comments:

Post a Comment